《CMI,6月23日,Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-24
  • Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

    Author links open overlay panelRoniBen-Ami1#AgnesKlochendler1#MatanSeidel2#TalSido3OriGurel-Gurevich4MoranYassour56EranMeshorer7GilBenedek8IritFogel8EstherOiknine-Djian8AsafGertler8ZeevRotstein8BrunoLavi8YuvalDor1Dana G.Wolf89MaayanSalton10YotamDrier9

    The Hebrew University-Hadassah COVID-19 diagnosis team

    Show more

    https://doi.org/10.1016/j.cmi.2020.06.009

    Abstract

    Objectives

    Testing for active SARS-CoV-2 infection is a fundamental tool in the public health measures taken to control the COVID-19 pandemic. Due to the overwhelming use of SARS-CoV-2 RT-PCR tests worldwide, availability of test kits has become a major bottleneck, while the need to increase testing throughput only rises. We aim to overcome these challenges by pooling samples together, performing RNA extraction and RT-PCR in pools.

    Methods

    We tested the efficiency and sensitivity of pooling strategies for RNA extraction and RT-PCR detection of SARS-CoV-2. We tested 184 samples both individually and in pools to estimate the effects of pooling. We further implemented Dorfman pooling with a pool size of 8 samples in large-scale clinical tests.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S1198743X20303499
相关报告
  • 《J Clinical Virology,6月23日,Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-24
    • Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits Author links open overlay panelAllen Wing-HoChuaWan-MuiChanaJonathan DanielIpaCyril Chik-YanYipbJasper Fuk-WooChanabKwok-YungYuenabKelvin Kai-WangToab Show more https://doi.org/10.1016/j.jcv.2020.104519 Abstract Background The severe shortage of nucleic acid extraction kits during the current COVID-19 pandemic represents a key limiting factor in testing capacity. Objectives This study compared the results of SARS-CoV-2 RT-PCR using different simple nucleic acid extraction methods on nasopharyngeal and saliva specimens.
  • 《Nature,9月23日,Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-10-14
    • Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR Ioanna Smyrlaki, Martin Ekman, Antonio Lentini, Nuno Rufino de Sousa, Natali Papanicolaou, Martin Vondracek, Johan Aarum, Hamzah Safari, Shaman Muradrasoli, Antonio Gigliotti Rothfuchs, Jan Albert, Björn Högberg & Björn Reinius Nature Communications volume 11, Article number: 4812 (2020) Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is commonly diagnosed by reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA in patient samples, but RNA extraction constitutes a major bottleneck in current testing. Methodological simplification could increase diagnostic availability and efficiency, benefitting patient care and infection control. Here, we describe methods circumventing RNA extraction in COVID-19 testing by performing RT-PCR directly on heat-inactivated or lysed samples. Our data, including benchmarking using 597 clinical patient samples and a standardised diagnostic system, demonstrate that direct RT-PCR is viable option to extraction-based tests. Using controlled amounts of active SARS-CoV-2, we confirm effectiveness of heat inactivation by plaque assay and evaluate various generic buffers as transport medium for direct RT-PCR. Significant savings in time and cost are achieved through RNA-extraction-free protocols that are directly compatible with established PCR-based testing pipelines. This could aid expansion of COVID-19 testing.